Neurent Medical
Neurent Medical is dedicated to transforming the treatment of Chronic Rhinitis through innovative, safe, and effective neuromodulation technology. Their mission is to develop solutions that target the root cause of nasal conditions, providing durable relief and improving patients' quality of life. The company emphasizes patient-centered care, relentless innovation, and integrity, with a focus on advancing nasal health with minimally invasive procedures.
Industries
Nr. of Employees
small (1-50)
Neurent Medical
150 Grossman Drive, Suite 203, Braintree, MA 02184
Patents
Products
Impedance‑controlled multipoint radiofrequency nasal neuromodulation system
A system combining a single‑use, hand‑held multipoint bipolar RF device and a reusable console with GUI that uses bioimpedance monitoring and conformable electrode leaflets to deliver targeted microablation to posterior nasal nerve pathways.
Impedance‑controlled multipoint radiofrequency nasal neuromodulation system
A system combining a single‑use, hand‑held multipoint bipolar RF device and a reusable console with GUI that uses bioimpedance monitoring and conformable electrode leaflets to deliver targeted microablation to posterior nasal nerve pathways.
Services
Personalized device demonstrations and training for ENT clinicians to support clinical adoption and technique standardization.
Assistance with prior authorization, appeals, billing inquiries and updates to support procedure reimbursement.
Multilingual brochures and educational resources for patient education and shared decision making.
Personalized device demonstrations and training for ENT clinicians to support clinical adoption and technique standardization.
Assistance with prior authorization, appeals, billing inquiries and updates to support procedure reimbursement.
Multilingual brochures and educational resources for patient education and shared decision making.
Expertise Areas
- Clinical trial management and outcomes research
- ENT procedural therapeutics for chronic rhinitis
- Medical device design and engineering (disposable handpiece + reusable console)
- Impedance‑controlled RF energy delivery and embedded control algorithms
Key Technologies
- Impedance‑controlled radiofrequency ablation
- Bioimpedance monitoring and closed‑loop energy control
- Multipoint bipolar electrode arrays
- Conformable leaflet electrode design
News & Updates
Cigna Healthcare has removed CPT 31242 posterior nasal nerve ablation using radiofrequency from its Experimental & Investigational list, effective September 15, 2025.
FDA has granted 510(k) clearance for the new NEUROMARK System, enabling broader U.S. access.
Recent studies show significant symptom improvements in patients treated with NEUROMARK.
510(k) Clearance for NEUROMARK System
FDA clearance for the next-generation device.
CPT Code 31242 Instated for Reimbursement
Allows insurance coverage for posterior nasal nerve ablation.
Cigna Healthcare has removed CPT 31242 posterior nasal nerve ablation using radiofrequency from its Experimental & Investigational list, effective September 15, 2025.
FDA has granted 510(k) clearance for the new NEUROMARK System, enabling broader U.S. access.
Recent studies show significant symptom improvements in patients treated with NEUROMARK.
510(k) Clearance for NEUROMARK System
FDA clearance for the next-generation device.
CPT Code 31242 Instated for Reimbursement
Allows insurance coverage for posterior nasal nerve ablation.